Bioanalytical readings return to normal following MSC administration, emphasizing the potential in managing COVID-19-induced complications. MSC therapy offers a potential solution for infection with the influenza virus, which is responsible for historical pandemics and epidemics, and remains a global health concern
StemCyte announced today that its Hematopoietic Progenitor Cell Cord Blood therapy (HPC Cord Blood) has officially obtained the Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration (FDA) for the treatment of Long COVID-19 syndrome
In the past year, 136 patients received treatment, leading to a total of 473 stem cell administrations. Patients who underwent the treatment experienced significant improvements in their physical functions, which included alleviating hand tremors, enhancing walking stability, and reducing symptoms of paralysis. Furthermore, notable advancements were observed in mental and psychological well-being, such as restored sleep quality, improved emotional stability, and decreased depressive symptoms.
Huge advances in technology make it possible to turn precursor cells, derived from pluripotent stem cells, into dopamine-producing neurons. We now can grow an almost unlimited number of these cells with a high degree of quality control.
People have been waiting a long time for a cure for Type 1 diabetes. Hannah Pizzato, PhD, is one of them.
Exciting developments reported in China with regenerative methods to treat diabetes
Without treatment, CAEBV patients develop progressive cellular and humoural immune deficiencies complicated by opportunistic infections, haemophagocytic lymphohistiocytosis (HLH), multiple organ failure, and lymphoma [4], often leading to death
Most people are carriers of EBV: 90% of the adult population are infected with the virus, usually experiencing no symptoms and no resulting illness. Around 50% become infected before the age of five, but many people don’t catch it until adolescence.
Stem cell therapy for inflammatory bowel disease (IBD) presents a revolutionary treatment path for individuals battling the relentless effects of conditions like Crohn’s disease and ulcerative colitis.
Stem cell therapy aims to help reduce the underlying inflammation in the mucous lining of your colon when other treatments haven’t worked.
The RHA.org - Your Trusted Guide to Regenerative Health
© 2024 All Rights Reserved.